150 related articles for article (PubMed ID: 4004283)
1. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
[TBL] [Abstract][Full Text] [Related]
3. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
5. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human interferon-alpha A/D on in vivo murine tumor cell growth.
Uno K; Shimizu S; Inaba K; Kitaura M; Nakahira K; Kato T; Yamaguchi Y; Muramatsu S
Cancer Res; 1988 May; 48(9):2366-71. PubMed ID: 3356004
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
9. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
Livingston PO; DeLeo AB; Jones M; Oettgen HF
J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
[TBL] [Abstract][Full Text] [Related]
10. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
11. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
[TBL] [Abstract][Full Text] [Related]
13. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
Haranaka K; Sakurai A; Satomi N
J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.
Kataoka T; Oh-hashi F; Sakurai Y; Usuki K; Ida N
Cancer Res; 1984 Dec; 44(12 Pt 1):5661-5. PubMed ID: 6498826
[TBL] [Abstract][Full Text] [Related]
16. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
Gomi K; Morimoto M; Nomoto K
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect of interferons].
Ebina T; Saito M
Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241
[TBL] [Abstract][Full Text] [Related]
18. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
20. Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide.
Silagi S; Schaefer AE
J Biol Response Mod; 1986 Oct; 5(5):411-22. PubMed ID: 3490544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]